On the public citation graph
3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade
0 signed · 322 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1007/978-3-319-45397-2openalex-snapshot
Ex Vivo Engineering of the Tumor Microenvironment
inferredcites →https://doi.org/10.1016/j.biomaterials.2017.10.005openalex-snapshot
Organ-on-chip models of cancer metastasis for future personalized medicine: From chip to the patient
inferredcites →https://doi.org/10.1016/j.bios.2014.07.029openalex-snapshot
Advantages and challenges of microfluidic cell culture in polydimethylsiloxane devices
inferredcites →https://doi.org/10.1016/j.biotechadv.2014.07.009openalex-snapshot
Three-dimensional in vitro tumor models for cancer research and drug evaluation
inferredcites →https://doi.org/10.1016/j.ccell.2015.03.001openalex-snapshot
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
inferredcites →https://doi.org/10.1016/j.cell.2016.05.082openalex-snapshot
Modeling Development and Disease with Organoids
inferredcites →https://doi.org/10.1016/j.cell.2017.11.010openalex-snapshot
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
inferredcites →https://doi.org/10.1016/j.ctrv.2016.11.007openalex-snapshot
Resistance to PD1/PDL1 checkpoint inhibition
inferredcites →https://doi.org/10.1016/j.gdata.2016.02.009openalex-snapshot
Transcriptional profiling of macrophage and tumor cell interactions in vitro
inferredcites →https://doi.org/10.1016/j.immuni.2016.06.001openalex-snapshot
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
inferredcites →https://doi.org/10.1016/j.molmed.2008.06.001openalex-snapshot
New dimensions in tumor immunology: what does 3D culture reveal?
inferredcites →https://doi.org/10.1016/j.molmed.2017.02.007openalex-snapshot
Disease Modeling in Stem Cell-Derived 3D Organoid Systems
inferredcites →https://doi.org/10.1016/j.tibtech.2015.09.009openalex-snapshot
Evaluating Biomaterial- and Microfluidic-Based 3D Tumor Models
inferredcites →https://doi.org/10.1016/s0065-2776(08)60911-6openalex-snapshot
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
inferredcites →https://doi.org/10.1038/bjc.2017.434openalex-snapshot
Mechanisms of resistance to immune checkpoint inhibitors
inferredcites →https://doi.org/10.1038/nature07935openalex-snapshot
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
inferredcites →https://doi.org/10.1038/nature13954openalex-snapshot
PD-1 blockade induces responses by inhibiting adaptive immune resistance
inferredcites →https://doi.org/10.1038/ncomms3126openalex-snapshot
Evaluating cell lines as tumour models by comparison of genomic profiles
inferredcites →https://doi.org/10.1038/nm.3853openalex-snapshot
Translational value of mouse models in oncology drug development
inferredcites →https://doi.org/10.1038/nm.4085openalex-snapshot
Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles
inferredcites →https://doi.org/10.1038/nm.4438openalex-snapshot
Human primary liver cancer–derived organoid cultures for disease modeling and drug screening
inferredcites →https://doi.org/10.1038/nmeth.3337openalex-snapshot
Robust enumeration of cell subsets from tissue expression profiles
inferredcites →https://doi.org/10.1038/nprot.2007.25openalex-snapshot
Establishment of human tumor xenografts in immunodeficient mice
inferredcites →https://doi.org/10.1038/nrc.2016.140openalex-snapshot
Interrogating open issues in cancer precision medicine with patient-derived xenografts
inferredcites →https://doi.org/10.1038/nrc.2017.92openalex-snapshot
Preclinical mouse solid tumour models: status quo, challenges and perspectives
inferredcites →https://doi.org/10.1038/nrc3239openalex-snapshot
The blockade of immune checkpoints in cancer immunotherapy
inferredcites →https://doi.org/10.1038/nrclinonc.2013.253openalex-snapshot
Molecular analysis of circulating tumour cells—biology and biomarkers
inferredcites →https://doi.org/10.1038/nrd4591openalex-snapshot
Combination cancer immunotherapy and new immunomodulatory targets
inferredcites →https://doi.org/10.1038/onc.2017.124openalex-snapshot
The RB–IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity
inferredcites →https://doi.org/10.1038/s41568-018-0007-6openalex-snapshot
Organoids in cancer research
inferredcites →https://doi.org/10.1038/s41591-018-0116-5openalex-snapshot
Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses
inferredcites →https://doi.org/10.1039/c2ib20209copenalex-snapshot
Screening therapeutic EMT blocking agents in a three-dimensional microenvironment
inferredcites →https://doi.org/10.1056/nejmc1509660openalex-snapshot
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1414428openalex-snapshot
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1504030openalex-snapshot
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
inferredcites →https://doi.org/10.1084/jem.20042028openalex-snapshot
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers
inferredcites →https://doi.org/10.1101/gad.305805.117openalex-snapshot
A conduit to metastasis: circulating tumor cell biology
inferredcites →https://doi.org/10.1158/0008-5472.can-08-4210openalex-snapshot
A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
inferredcites →https://doi.org/10.1158/0008-5472.can-17-1904openalex-snapshot
ER Stress Signaling Promotes the Survival of Cancer “Persister Cells” Tolerant to EGFR Tyrosine Kinase Inhibitors
inferredcites →https://doi.org/10.1158/1078-0432.ccr-15-0244openalex-snapshot
Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade
inferredcites →https://doi.org/10.1158/2159-8290.cd-15-1336openalex-snapshot
Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma
inferredcites →https://doi.org/10.1158/2159-8290.cd-17-0833openalex-snapshot
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
inferredcites →https://doi.org/10.1158/2159-8290.cd-17-0915openalex-snapshot
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation
inferredcites →https://doi.org/10.1159/000453569openalex-snapshot
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
inferredcites →https://doi.org/10.1159/000455014openalex-snapshot
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
inferredcites →https://doi.org/10.1172/jci.insight.89762openalex-snapshot
A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors
inferredcites →https://doi.org/10.1200/jco.2012.44.5932openalex-snapshot
Detection of Circulating Tumor Cells Harboring a Unique ALK Rearrangement in ALK -Positive Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1371/journal.pone.0130142openalex-snapshot
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
inferredcites →https://doi.org/10.1371/journal.pone.0159013openalex-snapshot
Co-Culture of Tumor Spheroids and Fibroblasts in a Collagen Matrix-Incorporated Microfluidic Chip Mimics Reciprocal Activation in Solid Tumor Microenvironment
inferredcites →https://doi.org/10.1373/clinchem.2015.242537openalex-snapshot
Functional Studies on Viable Circulating Tumor Cells
inferredcites →https://doi.org/10.1586/14737159.2015.1111139openalex-snapshot
The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer
inferredcites →https://doi.org/10.21037/tlcr.2017.07.01openalex-snapshot
Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time?
inferredcites →https://doi.org/10.21037/tlcr.2017.08.01openalex-snapshot
Circulating tumor cells and CDX models as a tool for preclinical drug development
inferredcites →https://doi.org/10.3389/fbioe.2016.00012openalex-snapshot
In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform
inferredcites →https://doi.org/10.3389/fendo.2016.00084openalex-snapshot
New 3D-Culture Approaches to Study Interactions of Bone Marrow Adipocytes with Metastatic Prostate Cancer Cells
inferredcites →https://doi.org/10.3390/ijms17091405openalex-snapshot
In Vitro Co-Culture Models of Breast Cancer Metastatic Progression towards Bone
inferredcites →https://doi.org/10.4049/jimmunol.1101245openalex-snapshot
The Process of Macrophage Migration Promotes Matrix Metalloproteinase-Independent Invasion by Tumor Cells
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/9783527818341.ch5openalex-snapshot
Microfluidics for Immuno‐oncology
inferred← citeshttps://doi.org/10.1002/adbi.202000133openalex-snapshot
Reconfigurable Microphysiological Systems for Modeling Innervation and Multitissue Interactions
inferred← citeshttps://doi.org/10.1002/adbi.202200312openalex-snapshot
Immunity‐on‐a‐Chip: Integration of Immune Components into the Scheme of Organ‐on‐a‐Chip Systems
inferred← citeshttps://doi.org/10.1002/adbi.202300077openalex-snapshot
Microphysiological Systems for Cancer Immunotherapy Research and Development
inferred← citeshttps://doi.org/10.1002/adfm.201807553openalex-snapshot
Microphysiological Systems as Enabling Tools for Modeling Complexity in the Tumor Microenvironment and Accelerating Cancer Drug Development
inferred← citeshttps://doi.org/10.1002/adfm.202215043openalex-snapshot
Advances in Spheroids and Organoids on a Chip
inferred← citeshttps://doi.org/10.1002/adfm.202400393openalex-snapshot
Dual‐Sensing Nanoreporter for Dynamic and High‐Throughput Monitoring of Immune Checkpoint Inhibitor Responses in Tumor‐Derived Organoids
inferred← citeshttps://doi.org/10.1002/adhm.201801198openalex-snapshot
Ex Vivo Tumor‐on‐a‐Chip Platforms to Study Intercellular Interactions within the Tumor Microenvironment
inferred← citeshttps://doi.org/10.1002/adhm.201801406openalex-snapshot
Analysis of Leukocyte Behaviors on Microfluidic Chips
inferred← citeshttps://doi.org/10.1002/adhm.201901486openalex-snapshot
Modeling Nanocarrier Transport across a 3D In Vitro Human Blood‐Brain–Barrier Microvasculature
inferred← citeshttps://doi.org/10.1002/adhm.202202279openalex-snapshot
Making In Vitro Tumor Models Whole Again
inferred← citeshttps://doi.org/10.1002/adhm.202400475openalex-snapshot
Imaging‐Based Efficacy Evaluation of Cancer Immunotherapy in Engineered Tumor Platforms and Tumor Organoids
inferred← citeshttps://doi.org/10.1002/adhm.202401927openalex-snapshot
Recapitulating the Cancer‐Immunity Cycle on a Chip
inferred← citeshttps://doi.org/10.1002/adhm.202503198openalex-snapshot
Harnessing Next‐Generation 3D Cancer Models to Elucidate Tumor‐Microbiome Crosstalk
inferred← citeshttps://doi.org/10.1002/adma.202210748openalex-snapshot
Microporogen‐Structured Collagen Matrices for Embedded Bioprinting of Tumor Models for Immuno‐Oncology
inferred← citeshttps://doi.org/10.1002/adsr.202300193openalex-snapshot
Cancer‐on‐Chip and Integrative Tumor Microenvironment Sensor Technologies for Progressing Precision Radiotherapy
inferred← citeshttps://doi.org/10.1002/adtp.202100017openalex-snapshot
Expansion of Rare Cancer Cells into Tumoroids for Therapeutic Regimen and Cancer Therapy
inferred← citeshttps://doi.org/10.1002/advs.202002825openalex-snapshot
Engineered Tools to Study Intercellular Communication
inferred← citeshttps://doi.org/10.1002/advs.202400185openalex-snapshot
Patient‐Derived Tumor Organoids Combined with Function‐Associated ScRNA‐Seq for Dissecting the Local Immune Response of Lung Cancer
inferred← citeshttps://doi.org/10.1002/advs.202402757openalex-snapshot
Personalized Vascularized Models of Breast Cancer Desmoplasia Reveal Biomechanical Determinants of Drug Delivery to the Tumor
inferred← citeshttps://doi.org/10.1002/advs.202500975openalex-snapshot
Advanced Microfluidics for Single Cell‐Based Cancer Research
inferred← citeshttps://doi.org/10.1002/advs.202503924openalex-snapshot
A Patient‐Derived Organoid Biobank of Adamantinomatous Craniopharyngioma as a Platform for Drug Discovery
inferred← citeshttps://doi.org/10.1002/bit.28221openalex-snapshot
All‐in‐one microfluidic design to integrate vascularized tumor spheroid into high‐throughput platform
inferred← citeshttps://doi.org/10.1002/cac2.12607openalex-snapshot
Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti‐PD‐1 therapy in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cam4.4114openalex-snapshot
Establishment of patient‐derived organotypic tumor spheroid models for tumor microenvironment modeling
inferred← citeshttps://doi.org/10.1002/cam4.6521openalex-snapshot
Patient‐derived organoid culture in epithelial ovarian cancers—Techniques, applications, and future perspectives
inferred← citeshttps://doi.org/10.1002/cbic.202400731openalex-snapshot
Evaluation of Multispecific Drugs Based on Patient‐Derived Immunocompetent Tumor Organoids
inferred← citeshttps://doi.org/10.1002/cti2.1400openalex-snapshot
Modelling the tumor immune microenvironment for precision immunotherapy
inferred← citeshttps://doi.org/10.1002/ijc.70347openalex-snapshot
Construction and immunotherapy application of lung cancer organoids
inferred← citeshttps://doi.org/10.1002/jcp.30135openalex-snapshot
Mesenchymal stem cells induce PD‐L1 expression through the secretion of CCL5 in breast cancer cells
inferred← citeshttps://doi.org/10.1002/mds3.10067openalex-snapshot
Three‐dimensional in vitro cell culture devices using patient‐derived cells for high‐throughput screening of drug combinations
inferred← citeshttps://doi.org/10.1002/med.22059openalex-snapshot
Targeted immunotherapy and nanomedicine for rhabdomyosarcoma: The way of the future
inferred← citeshttps://doi.org/10.1002/smtd.202000235openalex-snapshot
3D Immunocompetent Organ‐on‐a‐Chip Models
inferred← citeshttps://doi.org/10.1002/smtd.202301009openalex-snapshot
Next‐Generation Preclinical Functional Testing Models in Cancer Precision Medicine: CTC‐Derived Organoids
inferred← citeshttps://doi.org/10.1007/978-1-0716-2513-2_4openalex-snapshot
Generation and Culture of Organotypic Breast Carcinoma Spheroids for the Study of Drug Response in a 3D Microfluidic Device
inferred← citeshttps://doi.org/10.1007/978-1-0716-3056-3_3openalex-snapshot
Three-Dimensional Spheroids for Cancer Research
inferred← citeshttps://doi.org/10.1007/978-3-030-35723-8_7openalex-snapshot
Models for Monocytic Cells in the Tumor Microenvironment
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_206-1openalex-snapshot
Preclinical Cancer Models for the Evaluation of Immunotherapies: From Cell Lines to Animal Models
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_285-1openalex-snapshot
Use of Organoids in Cancer: A New Therapeutic and Research Approach
inferred← citeshttps://doi.org/10.1007/978-3-032-00767-4_206openalex-snapshot
Preclinical Cancer Models for the Evaluation of Immunotherapies: From Cell Lines to Animal Models
inferred← citeshttps://doi.org/10.1007/978-3-032-00771-1_285openalex-snapshot
Use of Organoids in Cancer: A New Therapeutic and Research Approach
inferred← citeshttps://doi.org/10.1007/978-981-19-1282-5_12-1openalex-snapshot
Bioreactor-Based Tissue Models as an Alternative Approach in Cancer Research
inferred← citeshttps://doi.org/10.1007/978-981-19-3824-5_12openalex-snapshot
Bioreactor-Based Tissue Models as an Alternative Approach in Cancer Research
inferred← citeshttps://doi.org/10.1007/978-981-19-9786-0_15openalex-snapshot
Microfluidics and Cancer Treatment: Emerging Concept of Biomedical Engineering
inferred← citeshttps://doi.org/10.1007/s10637-025-01523-wopenalex-snapshot
Patient-derived tumor organoids for cancer immunotherapy: culture techniques and clinical application
inferred← citeshttps://doi.org/10.1007/s13770-020-00258-4openalex-snapshot
In Vitro Modeling of the Tumor Microenvironment in Tumor Organoids
inferred← citeshttps://doi.org/10.1007/s40257-024-00907-7openalex-snapshot
Overcoming Resistance Mechanisms to Melanoma Immunotherapy
inferred← citeshttps://doi.org/10.1007/s42242-020-00080-wopenalex-snapshot
Engineering in vitro human tissue models through bio-design and manufacturing
inferred← citeshttps://doi.org/10.1016/b978-0-12-818128-7.00019-8openalex-snapshot
Tissue-engineered 3D cancer microenvironment for screening therapeutics
inferred← citeshttps://doi.org/10.1016/b978-0-323-90949-5.00006-1openalex-snapshot
Tumor-on-a-chip devices for cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/b978-0-443-15518-5.00009-4openalex-snapshot
Commercial and regulatory challenges in cancer nanomedicine
inferred← citeshttps://doi.org/10.1016/bs.acc.2020.02.012openalex-snapshot
Application of microfluidic technology in cancer research and therapy
inferred← citeshttps://doi.org/10.1016/bs.mcb.2024.11.003openalex-snapshot
Preparation and analysis of monotypic and organotypic tumor spheroids
inferred← citeshttps://doi.org/10.1016/j.actbio.2021.03.076openalex-snapshot
Engineered in vitro tumor models for cell-based immunotherapy
inferred← citeshttps://doi.org/10.1016/j.actbio.2021.06.025openalex-snapshot
High-throughput microfluidic 3D biomimetic model enabling quantitative description of the human breast tumor microenvironment
inferred← citeshttps://doi.org/10.1016/j.addr.2021.03.015openalex-snapshot
Immunocompetent cancer-on-chip models to assess immuno-oncology therapy
inferred← citeshttps://doi.org/10.1016/j.addr.2021.05.008openalex-snapshot
Tumor-on-chip modeling of organ-specific cancer and metastasis
inferred← citeshttps://doi.org/10.1016/j.addr.2022.114365openalex-snapshot
Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment
inferred← citeshttps://doi.org/10.1016/j.bbcan.2022.188717openalex-snapshot
Organ-on-Chip platforms to study tumor evolution and chemosensitivity
inferred← citeshttps://doi.org/10.1016/j.bbcan.2024.189235openalex-snapshot
Organoids in lung cancer brain metastasis: Foundational research, clinical translation, and prospective outlooks
inferred← citeshttps://doi.org/10.1016/j.bbcan.2026.189627openalex-snapshot
A comprehensive review of microfluidic-based organ-on-chip technology in the application of preclinical drug discovery studies
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2020.120416openalex-snapshot
Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine
inferred← citeshttps://doi.org/10.1016/j.bios.2023.115064openalex-snapshot
Spatiotemporal dissection of tumor microenvironment via in situ sensing and monitoring in tumor-on-a-chip
inferred← citeshttps://doi.org/10.1016/j.ccell.2021.05.017openalex-snapshot
Developing and validating model systems for immuno-oncology
inferred← citeshttps://doi.org/10.1016/j.ccell.2021.07.020openalex-snapshot
Tumor organoids: Opportunities and challenges to guide precision medicine
inferred← citeshttps://doi.org/10.1016/j.ccell.2022.08.015openalex-snapshot
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer
inferred← citeshttps://doi.org/10.1016/j.ccell.2026.02.008openalex-snapshot
Vascular STING activation facilitates NK cell anti-tumor immunity in small cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.cej.2024.150036openalex-snapshot
Triggering triboelectric nanogenerator antibacterial Activities: Effect of charge polarity and host material correlation
inferred← citeshttps://doi.org/10.1016/j.cireng.2026.800285openalex-snapshot
Modelling the colorectal cancer immune microenvironment using air–liquid interface organoids for personalised therapeutic evaluation
inferred← citeshttps://doi.org/10.1016/j.ciresp.2026.800285openalex-snapshot
Modelling the colorectal cancer immune microenvironment using air–liquid interface organoids for personalised therapeutic evaluation
inferred← citeshttps://doi.org/10.1016/j.cobme.2020.03.005openalex-snapshot
Bioengineered tumor organoids
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2024.114435openalex-snapshot
The biological macromolecules constructed Matrigel for cultured organoids in biomedical and tissue engineering
inferred← citeshttps://doi.org/10.1016/j.dmpk.2024.101003openalex-snapshot
DMPK perspective on quantitative model analysis for chimeric antigen receptor cell therapy: Advances and challenges
inferred← citeshttps://doi.org/10.1016/j.drudis.2020.11.028openalex-snapshot
Bioengineered tissue models for the development of dynamic immuno-associated tumor models and high-throughput immunotherapy cytotoxicity assays
inferred← citeshttps://doi.org/10.1016/j.drup.2019.100658openalex-snapshot
Advanced technological tools to study multidrug resistance in cancer
inferred← citeshttps://doi.org/10.1016/j.ejca.2022.11.010openalex-snapshot
Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors
inferred← citeshttps://doi.org/10.1016/j.ejcped.2026.100533openalex-snapshot
Patient-derived organoid in vitro models for antibody-based immunotherapy in pediatric solid tumors
inferred← citeshttps://doi.org/10.1016/j.fmre.2023.12.019openalex-snapshot
Advances in human organs-on-chips and applications for drug screening and personalized medicine
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e32546openalex-snapshot
Inspiring a convergent engineering approach to measure and model the tissue microenvironment
inferred← citeshttps://doi.org/10.1016/j.intimp.2025.115449openalex-snapshot
Tumor organoids targeted by receptor-engineered immune cells: A promising approach for advancing cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.isci.2020.101985openalex-snapshot
Engineering approaches for studying immune-tumor cell interactions and immunotherapy
inferred← citeshttps://doi.org/10.1016/j.isci.2021.102179openalex-snapshot
Engineered models of tumor metastasis with immune cell contributions
inferred← citeshttps://doi.org/10.1016/j.it.2020.06.010openalex-snapshot
Organoid Models of Tumor Immunology
inferred← citeshttps://doi.org/10.1016/j.jcis.2023.01.079openalex-snapshot
Oxygen-Rich Graphene/ZnO2-Ag nanoframeworks with pH-Switchable Catalase/Peroxidase activity as O2 Nanobubble-Self generator for bacterial inactivation
inferred← citeshttps://doi.org/10.1016/j.jncc.2022.10.001openalex-snapshot
Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models
inferred← citeshttps://doi.org/10.1016/j.mtbio.2024.101028openalex-snapshot
Semiconducting polymer dots for multifunctional integrated nanomedicine carriers
inferred← citeshttps://doi.org/10.1016/j.nanoen.2023.108510openalex-snapshot
Irreversible electroporation for post-operative margin therapy to prevent cancer recurrence based on triboelectric nanogenerator driven balloon catheter
inferred← citeshttps://doi.org/10.1016/j.nxmate.2024.100229openalex-snapshot
Cells in the 3D biomatrix on-chip: better mimicking the real micro-physiological system
inferred← citeshttps://doi.org/10.1016/j.onano.2023.100134openalex-snapshot
Promises and challenges for targeting the immunological players in the tumor micro-environment – Critical determinants for NP-based therapy
inferred← citeshttps://doi.org/10.1016/j.preme.2025.100030openalex-snapshot
Strategies for the vascularization and immune modeling of human tumor organoids based on advanced technologies
inferred← citeshttps://doi.org/10.1016/j.prp.2024.155231openalex-snapshot
Patient-derived melanoma models
inferred← citeshttps://doi.org/10.1016/j.reth.2023.12.011openalex-snapshot
Liver organoids and their application in liver cancer research
inferred← citeshttps://doi.org/10.1016/j.tibtech.2020.01.003openalex-snapshot
Engineering Microphysiological Immune System Responses on Chips
inferred← citeshttps://doi.org/10.1016/j.tibtech.2021.08.007openalex-snapshot
3D-bioprinted cancer-on-a-chip: level-up organotypic in vitro models
inferred← citeshttps://doi.org/10.1016/j.tibtech.2022.04.003openalex-snapshot
A hitchhiker’s guide to cancer models
inferred← citeshttps://doi.org/10.1016/j.trecan.2022.06.001openalex-snapshot
Immune organoids: from tumor modeling to precision oncology
inferred← citeshttps://doi.org/10.1016/j.xcrm.2024.101549openalex-snapshot
Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip
inferred← citeshttps://doi.org/10.1016/j.xcrm.2025.102198openalex-snapshot
Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platform
inferred← citeshttps://doi.org/10.1016/j.xcrm.2025.102210openalex-snapshot
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants
inferred← citeshttps://doi.org/10.1016/j.xphs.2024.06.016openalex-snapshot
Applications of Organoids in Advancing Drug Discovery and Development
inferred← citeshttps://doi.org/10.1016/j.xpro.2025.104286openalex-snapshot
Protocol for the preparation and analysis of patient-derived organotypic tumor spheroids
inferred← citeshttps://doi.org/10.1016/j.yexcr.2021.112858openalex-snapshot
Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold
inferred← citeshttps://doi.org/10.1021/acs.chemrev.0c00356openalex-snapshot
Engineering in Medicine To Address the Challenge of Cancer Drug Resistance: From Micro- and Nanotechnologies to Computational and Mathematical Modeling
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.0c01542openalex-snapshot
Microfluidic Tumor Vasculature Model to Recapitulate an Endothelial Immune Barrier Expressing FasL
inferred← citeshttps://doi.org/10.1038/s41378-020-0164-0openalex-snapshot
Microfluidics for interrogating live intact tissues
inferred← citeshttps://doi.org/10.1038/s41378-024-00756-8openalex-snapshot
Microdissection tools to generate organoids for modeling the tumor immune microenvironment
inferred← citeshttps://doi.org/10.1038/s41388-021-01723-7openalex-snapshot
Recent advances in preclinical models for lung squamous cell carcinoma
inferred← citeshttps://doi.org/10.1038/s41417-020-00248-7openalex-snapshot
The future of microfluidics in immune checkpoint blockade
inferred← citeshttps://doi.org/10.1038/s41420-023-01354-9openalex-snapshot
Organoids and organs-on-chips: insights into predicting the efficacy of systemic treatment in colorectal cancer
inferred← citeshttps://doi.org/10.1038/s41467-021-23238-1openalex-snapshot
Microfluidic platform accelerates tissue processing into single cells for molecular analysis and primary culture models
inferred← citeshttps://doi.org/10.1038/s41467-022-30384-7openalex-snapshot
A role for microfluidic systems in precision medicine
inferred← citeshttps://doi.org/10.1038/s41467-024-55378-5openalex-snapshot
Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment
inferred← citeshttps://doi.org/10.1038/s41467-026-68768-8openalex-snapshot
Cycling molecular assemblies for Golgi imaging and disruption
inferred← citeshttps://doi.org/10.1038/s41467-026-72372-1openalex-snapshot
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancer
inferred← citeshttps://doi.org/10.1038/s41568-024-00706-6openalex-snapshot
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
inferred← citeshttps://doi.org/10.1038/s41571-023-00745-2openalex-snapshot
Functional precision oncology using patient-derived assays: bridging genotype and phenotype
inferred← citeshttps://doi.org/10.1038/s41575-020-00386-1openalex-snapshot
Human biomimetic liver microphysiology systems in drug development and precision medicine
inferred← citeshttps://doi.org/10.1038/s41575-024-00968-3openalex-snapshot
Intestinal organ chips for disease modelling and personalized medicine
inferred← citeshttps://doi.org/10.1038/s41586-023-05704-6openalex-snapshot
Targeting TBK1 to overcome resistance to cancer immunotherapy
inferred← citeshttps://doi.org/10.1038/s41598-020-67674-3openalex-snapshot
Deterministic culturing of single cells in 3D
inferred← citeshttps://doi.org/10.1038/s41598-020-70785-6openalex-snapshot
Real time monitoring of oxygen uptake of hepatocytes in a microreactor using optical microsensors
inferred← citeshttps://doi.org/10.1038/s41598-022-11023-zopenalex-snapshot
Radiobiological effects of wound fluid on breast cancer cell lines and human-derived tumor spheroids in 2D and microfluidic culture
inferred← citeshttps://doi.org/10.1038/s41698-022-00333-0openalex-snapshot
Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy
inferred← citeshttps://doi.org/10.1038/s41698-024-00661-3openalex-snapshot
Probing the killing potency of tumor-infiltrating lymphocytes on microarrayed colorectal cancer tumoroids
inferred← citeshttps://doi.org/10.1038/s42003-025-09390-0openalex-snapshot
Microgravity-cultured glioblastoma organoids integrated with microfluidic chip for CAR-γδ T evaluation
inferred← citeshttps://doi.org/10.1038/s43018-022-00427-5openalex-snapshot
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes
inferred← citeshttps://doi.org/10.1038/s43856-025-01359-8openalex-snapshot
High-throughput spheroid-based assay for functional breast cancer precision medicine facilitated by deep learning
inferred← citeshttps://doi.org/10.1038/s44222-023-00105-wopenalex-snapshot
Synthetic living materials in cancer biology
inferred← citeshttps://doi.org/10.1039/9781839166013-00279openalex-snapshot
Modeling of the Tumor Microenvironment in Tumor Organoids
inferred← citeshttps://doi.org/10.1039/c9lc00811jopenalex-snapshot
A microfluidic platform for functional testing of cancer drugs on intact tumor slices
inferred← citeshttps://doi.org/10.1039/d0lc00799dopenalex-snapshot
Tumor-on-a-chip platforms to study cancer–immune system crosstalk in the era of immunotherapy
inferred← citeshttps://doi.org/10.1039/d0lc00801jopenalex-snapshot
Microdissected “cuboids” for microfluidic drug testing of intact tissues
inferred← citeshttps://doi.org/10.1039/d0lc01305fopenalex-snapshot
Microfluidic technologies for immunotherapy studies on solid tumours
inferred← citeshttps://doi.org/10.1039/d1lc00550bopenalex-snapshot
Hybrid skin chips for toxicological evaluation of chemical drugs and cosmetic compounds
inferred← citeshttps://doi.org/10.1039/d1lc00749aopenalex-snapshot
Generation of flow and droplets with an ultra-long-range linear concentration gradient
inferred← citeshttps://doi.org/10.1039/d2ra02008dopenalex-snapshot
Development of nano- and microdevices for the next generation of biotechnology, wearables and miniaturized instrumentation
inferred← citeshttps://doi.org/10.1039/d3lc00124eopenalex-snapshot
Manufactured tissue-to-tissue barrier chip for modeling the human blood–brain barrier and regulation of cellular trafficking
inferred← citeshttps://doi.org/10.1039/d5lc00062aopenalex-snapshot
Patient-derived organotypic tumor spheroids, tumoroids, and organoids: advancing immunotherapy using state-of-the-art 3D tumor model systems
inferred← citeshttps://doi.org/10.1039/d5lc00526dopenalex-snapshot
Behaviorome profiling of anti-tumor and pro-tumor human neutrophil subtypes in a microphysiological system
inferred← citeshttps://doi.org/10.1039/d6lc00574hopenalex-snapshot
Differential modulation of exhausted Th1 cell migration by immune checkpoint blockade: insights from 3D microfluidic and in vivo PDX platforms
inferred← citeshttps://doi.org/10.1049/enb2.12015openalex-snapshot
Recent advances of integrated microfluidic suspension cell culture system
inferred← citeshttps://doi.org/10.1055/s-0040-1719084openalex-snapshot
Physiomimetic Models of Adenomyosis
inferred← citeshttps://doi.org/10.1063/5.0026857openalex-snapshot
Toward improved in vitro models of human cancer
inferred← citeshttps://doi.org/10.1063/5.0108792openalex-snapshot
Recent advances in microfluidic-based cancer immunotherapy-on-a-chip strategies
inferred← citeshttps://doi.org/10.1073/pnas.1905005116openalex-snapshot
Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade
inferred← citeshttps://doi.org/10.1088/1361-6439/ad0d7fopenalex-snapshot
Combination of anti-miR19a-3p polyplex plus doxorubicin for breast cancer in 2D culture and apoptosis assay in 3D spheroids in a microwell device
inferred← citeshttps://doi.org/10.1088/1758-5090/acd1b8openalex-snapshot
Reconstruction of tumor microenvironment via in vitro three-dimensional models
inferred← citeshttps://doi.org/10.1088/1758-5090/ad9b50openalex-snapshot
Modeling intratumor heterogeneity in breast cancer
inferred← citeshttps://doi.org/10.1089/ten.teb.2019.0302openalex-snapshot
Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma
inferred← citeshttps://doi.org/10.1089/ten.tec.2020.0300openalex-snapshot
Applications of Omics Technologies for Three-Dimensional In Vitro Disease Models
inferred← citeshttps://doi.org/10.1101/2021.03.24.436761openalex-snapshot
Evaluation of solvents used for fabrication of microphysiological systems
inferred← citeshttps://doi.org/10.1101/2021.03.30.437679openalex-snapshot
Probing the killing potency of tumor-infiltrating lymphocytes on microarrayed autologous tumoroids
inferred← citeshttps://doi.org/10.1101/2021.05.19.21257378openalex-snapshot
Evaluation of Tumor Response to Adjuvant Treatments using an Ex Vivo Culture of Breast Carcinoma Spheroids in a Microfluidic Device
inferred← citeshttps://doi.org/10.1101/2021.12.12.472296openalex-snapshot
Personalized models of breast cancer desmoplasia reveal biomechanical determinants of drug penetration
inferred← citeshttps://doi.org/10.1101/2022.07.07.499178openalex-snapshot
A 96-WELL VALVED MICROFLUIDIC DEVICE FOR TESTING OF LIVE INTACT TUMOR CUBOIDS
inferred← citeshttps://doi.org/10.1101/2023.06.21.545960openalex-snapshot
Ex vivo quantification of anti-tumor T-cell activity upon anti-PD-1 treatment in patient-derived lung tumor-on-chip
inferred← citeshttps://doi.org/10.1101/2023.12.11.571047openalex-snapshot
Function-associated scRNA-seq on single lung cancer organoids unravels the immune landscape of tumor parenchyma
inferred← citeshttps://doi.org/10.1101/2024.02.12.579184openalex-snapshot
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy
inferred← citeshttps://doi.org/10.1101/2024.03.22.586189openalex-snapshot
Functional evaluation of microdissected tumor ‘cuboids’: a microscale ex vivo cancer model that retains a complex tumor microenvironment
inferred← citeshttps://doi.org/10.1111/ejh.14448openalex-snapshot
Construction of Lymphoma Organoids and Applications in Tumor Microenvironment Research
inferred← citeshttps://doi.org/10.1111/exd.14675openalex-snapshot
From simplicity to complexity in current melanoma models
inferred← citeshttps://doi.org/10.1111/jcmm.16578openalex-snapshot
Organoid models of the tumor microenvironment and their applications
inferred← citeshttps://doi.org/10.1126/sciadv.ads1631openalex-snapshot
Low-cost robotic manipulation of live microtissues for cancer drug testing
inferred← citeshttps://doi.org/10.1126/scitranslmed.abo3826openalex-snapshot
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma
inferred← citeshttps://doi.org/10.1134/s1990519x20060097openalex-snapshot
Cultivation of Melanoma Cells in vitro on a 3D Scaffold Prepared on the Basis of Gelatin
inferred← citeshttps://doi.org/10.1136/jitc-2023-sitc2023.0561openalex-snapshot
561 Targeting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy
inferred← citeshttps://doi.org/10.1146/annurev-cancerbio-061421-040659openalex-snapshot
Engineering the Immune Microenvironment into Organoid Models
inferred← citeshttps://doi.org/10.11569/wcjd.v29.i11.563openalex-snapshot
Application and research progress of in vitro liver cancer cell culture models
inferred← citeshttps://doi.org/10.11569/wcjd.v31.i24.989openalex-snapshot
Preclinical liver cancer models in the context of immunoprecision therapy: Application and perspectives
inferred← citeshttps://doi.org/10.1158/0008-5472.can-23-1711openalex-snapshot
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-19-1844openalex-snapshot
Use of Ex Vivo Patient-Derived Tumor Organotypic Spheroids to Identify Combination Therapies for HER2 Mutant Non–Small Cell Lung Cancer
inferred← citeshttps://doi.org/10.1158/1535-7163.c.6543268.v1openalex-snapshot
Data from 3D Collagen Vascular Tumor-on-a-Chip Mimetics for Dynamic Combinatorial Drug Screening
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-20-0880openalex-snapshot
3D Collagen Vascular Tumor-on-a-Chip Mimetics for Dynamic Combinatorial Drug Screening
inferred← citeshttps://doi.org/10.1158/2159-8290.cd-20-0913openalex-snapshot
Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity
inferred← citeshttps://doi.org/10.1158/2159-8290.cd-23-0700openalex-snapshot
TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity
inferred← citeshttps://doi.org/10.1158/2326-6066.cir-22-0017openalex-snapshot
Activation of Tumor-Cell STING Primes NK-Cell Therapy
inferred← citeshttps://doi.org/10.1158/2326-6066.cir-23-1011openalex-snapshot
TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
inferred← citeshttps://doi.org/10.1158/2326-6066.cir-25-0156openalex-snapshot
Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies
inferred← citeshttps://doi.org/10.1172/jci135038openalex-snapshot
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade
inferred← citeshttps://doi.org/10.1186/s12929-025-01209-8openalex-snapshot
Tumor-on-chip’s alliance with molecular pathology against metastatic disease
inferred← citeshttps://doi.org/10.1186/s12935-024-03628-3openalex-snapshot
Novel research model for in vitro immunotherapy: co-culturing tumor organoids with peripheral blood mononuclear cells
inferred← citeshttps://doi.org/10.1186/s12943-023-01916-6openalex-snapshot
Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine
inferred← citeshttps://doi.org/10.1186/s12943-024-01952-wopenalex-snapshot
Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects
inferred← citeshttps://doi.org/10.1186/s12957-023-03231-2openalex-snapshot
Breast cancer organoids and their applications for precision cancer immunotherapy
inferred← citeshttps://doi.org/10.1186/s12967-024-05824-1openalex-snapshot
Advancing cancer research through organoid technology
inferred← citeshttps://doi.org/10.1186/s12967-025-06349-xopenalex-snapshot
Reproducible extracellular matrices for tumor organoid culture: challenges and opportunities
inferred← citeshttps://doi.org/10.1186/s13046-019-1086-2openalex-snapshot
3D models in the new era of immune oncology: focus on T cells, CAF and ECM
inferred← citeshttps://doi.org/10.1186/s40164-026-00757-5openalex-snapshot
Methods and applications of patient-derived organoid models for immune microenvironment and immunotherapy research in multiple cancer types
inferred← citeshttps://doi.org/10.12688/openreseurope.13335.1openalex-snapshot
The challenges and considerations for emerging or future entrepreneurial researchers in microphysiological systems
inferred← citeshttps://doi.org/10.1371/journal.pcbi.1013973openalex-snapshot
Bridging cancer cell-intrinsic driver genes and -extrinsic cell-cell communication with Driver2Comm
inferred← citeshttps://doi.org/10.1530/eo-24-0038openalex-snapshot
Multifaceted modeling of small intestinal neuroendocrine tumors
inferred← citeshttps://doi.org/10.17816/onco516562openalex-snapshot
Three-dimensional cell models for studying tumor–immune interactions and testing immunotherapeutic drugs
inferred← citeshttps://doi.org/10.20517/2394-5079.2025.118openalex-snapshot
Patient-derived tumor organoid models for functional precision oncology in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.21037/tlcr.2017.07.01openalex-snapshot
Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time?
inferred← citeshttps://doi.org/10.22465/kjuo.2021.19.4.197openalex-snapshot
Patient-Specific Tumor Microenvironment Models
inferred← citeshttps://doi.org/10.2745/dds.39.184openalex-snapshot
Design patterns of tumor-on-chips utilizing fluidic devices and their latest trends
inferred← citeshttps://doi.org/10.33263/biomed11.002008openalex-snapshot
Microfluidics – Organ-on-chip
showing the first 200 of 264 · page through all 264
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.